Polysorbate 20 degradation in biotherapeutic formulations and its

Enzyme-induced hydrolysis of polysorbate 20 and formation of subvisible particles was evaluated using relevant analytical techniques to understand the impact of

Pharmaceutics, Free Full-Text

Polysorbate 20 Degradation in Biopharmaceutical Formulations: Quantification of Free Fatty Acids, Characterization of Particulates, and Insights into the Degradation Mechanism

Nelli Erwin on LinkedIn: Poloxamer 188 as surfactant in biological formulations – An alternative…

Activity-Based Protein Profiling: High-Risk HCPs - BioProcess InternationalBioProcess International

Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways - Journal of Pharmaceutical Sciences

Profiling Active Enzymes for Polysorbate Degradation in Biotherapeutics by Activity-Based Protein Profiling

Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases

Polysorbate 20 Degradation in Biopharmaceutical Formulations: Quantification of Free Fatty Acids, Characterization of Particulates, and Insights into the Degradation Mechanism

Polysorbate 20 Degradation in Biopharmaceutical Formulations: Quantification of Free Fatty Acids, Characterization of Particulates, and Insights into the Degradation Mechanism

Pharmaceutics, Free Full-Text

Novel markers to track oxidative polysorbate degradation in pharmaceutical formulations

Quantifying, Profiling Polysorbates with Charged Aerosol Detection - Analytical Methods

View of ANALYSIS OF POLYSORBATE 80 SOLUTION STABILITY UNDER STRESS CONDITIONS TO ENSURE ITS QUALITY AS A BIOPHARMACEUTICAL EXCIPIENT